Damien Basille
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Damien Basille has a total of 170 co-authors. Here are the top co-authors by number of shared publications:
Vincent Jounieaux
Pneumology Department, University Hospital Centre Amiens-Picardie, Amiens, France; AGIR Unit, University Picardie Jules Vernes, Amiens, France
12 shared publicationsClaire Andrejak
10 shared publications- Aurélien Dinh
Infectious Diseases department, R. Poincaré University Hospital, APHP, Garches, France
4 shared publications Marianne Auquier
Department of radiology CHU Amiens, Amiens, France
4 shared publications- Olivier Leleu
Department of pulmonology and thoracic oncology Centre Hospitalier Abbeville, Abbeville Cedex, France
4 shared publications Pascal Berna
Department of Thoracic Surgery CHU Amiens, France
4 shared publications
Latest Publications
- Open Access
- 4 May 2026
- Published by Elsevier in SSRN Electronic Journal
Resectable non-small cell lung cancer with negative endobronchial ultrasound: Identifying candidates for confirmatory mediastinoscopy (the Octopus study)
Background:Accurate mediastinal staging is essential in non–small cell lung cancer (NSCLC). Endobronchial ultrasound–guided transbronchial needle aspiration (EBUS) is recommended as first-line, with a confirmatory mediastinoscopy in case of negative EBUS. However, unforeseen mediastinal nodal involvement (uN+) remains a challenge in routine practice.Methods:The OCTOPUS study is a retrospective single-center analysis performed in patients who underwent EBUS followed by a curative-intent thoracic surgery in our tertiary center (2008–2023). Patients with positive EBUS, non-NSCLC, or receiving neoadjuvant therapy were excluded from the study. The primary endpoint was the rate of uN+ (N2/N3 disease at curative-intent thoracic surgery after negative EBUS). Secondary outcomes included predictive factors and impact on overall survival (OS) and progression-free survival (PFS).Results:One hundred and seventeen patients were included with a mean of 1.96 ± 0.95 sampled stations per EBUS procedure. Overall, 20 patients (17.1%) had uN+. The prevalence of uN+ tended to decrease over time (27.5% in 2008–2013 vs. 9.5% in 2019–2023; p=0.084). Multidisciplinary tumor board (MTB) recommended mediastinoscopy in 33 patients, detecting 6 uN+ (18.2%) and avoiding futile surgery. Three additional uN+ were detected in the remaining 27 patients with a negative mediastinoscopy (11.1%). In patients proceeding directly to surgery (n=84), 11 uN+ (13.1%) were identified. No factor significantly predicted uN+, although absence of 4L sampling, central tumor location, and use of mediastinoscopy showed non-significant trends. OS and PFS were significantly reduced in uN+ patients, irrespective of diagnosis method.Conclusion:Despite improvement in EBUS performance, unforeseen nodal disease persists in nearly one in six NSCLC patients after a negative EBUS staging. MTB-guided mediastinoscopy can reduce futile surgeries and improve outcomes, supporting its integration into modern staging algorithms.
- 4 May 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessResectable non-small cell lung cancer with negative endobronchial ultrasound: Identifying candidates for confirmatory mediastinoscopy (the Octopus study)
Background:Accurate mediastinal staging is essential in non–small cell lung cancer (NSCLC). Endobronchial ultrasound–guided transbronchial needle aspiration (EBUS) is recommended as first-line, with a confirmatory mediastinoscopy in case of negative EBUS. However, unforeseen mediastinal nodal involvement (uN+) remains a challenge in routine practice.Methods:The OCTOPUS study is a retrospective single-center analysis performed in patients who underwent EBUS followed by a curative-intent thoracic surgery in our tertiary center (2008–2023). Patients with positive EBUS, non-NSCLC, or receiving neoadjuvant therapy were excluded from the study. The primary endpoint was the rate of uN+ (N2/N3 disease at curative-intent thoracic surgery after negative EBUS). Secondary outcomes included predictive factors and impact on overall survival (OS) and progression-free survival (PFS).Results:One hundred and seventeen patients were included with a mean of 1.96 ± 0.95 sampled stations per EBUS procedure. Overall, 20 patients (17.1%) had uN+. The prevalence of uN+ tended to decrease over time (27.5% in 2008–2013 vs. 9.5% in 2019–2023; p=0.084). Multidisciplinary tumor board (MTB) recommended mediastinoscopy in 33 patients, detecting 6 uN+ (18.2%) and avoiding futile surgery. Three additional uN+ were detected in the remaining 27 patients with a negative mediastinoscopy (11.1%). In patients proceeding directly to surgery (n=84), 11 uN+ (13.1%) were identified. No factor significantly predicted uN+, although absence of 4L sampling, central tumor location, and use of mediastinoscopy showed non-significant trends. OS and PFS were significantly reduced in uN+ patients, irrespective of diagnosis method.Conclusion:Despite improvement in EBUS performance, unforeseen nodal disease persists in nearly one in six NSCLC patients after a negative EBUS staging. MTB-guided mediastinoscopy can reduce futile surgeries and improve outcomes, supporting its integration into modern staging algorithms.
- 4 April 2026
- Published by Agence Bibliographique de l'Enseignement Supérieur
Complications pleuroparenchymateuses des pneumopathies aiguës communautaires : facteurs de risque, prise en charge diagnostique et thérapeutique
Les complications pleuropulmonaires (pleurésies infectieuses et abcès pulmonaires) des pneumopathies aiguës communautaires (PAC) sont associées à une morbidité importante mais leurs facteurs de risque et leur prise en charge sont toujours source de débat. Nous avons observé dans 2 études de cohorte (CAPAINS et CAPAINS-2) que l'utilisation d'anti-inflammatoires non stéroïdiens était associée à un risque accru de complications pleuropulmonaires, en particulier chez les patients jeunes et sans comorbidité. Dans une 3ème cohorte de patients BPCO hospitalisés pour une PAC, nous avons trouvé que l'utilisation de corticostéroïdes inhalés n'était pas associée à une modification du risque de complication pleuropulmonaire mais à une diminution de la mortalité, principalement chez les patients exacerbateurs fréquents ou avec un diagnostic de BPCO ancien (> 1 an). Finalement, nous avons mis en place une 4ème étude de cohorte pour évaluer l'impact du diabète et du contrôle glycémique sur l'évolution des PAC. Nous avons conduit une étude prospective évaluant la détection des pleurésies parapneumoniques par la réalisation d'une échographie thoracique quotidienne. Dans une analyse préliminaire, nous avons observé que près des 2/3 des patients présentaient une pleurésie parapneumonique et que l'échographie pleurale était plus sensible que la radiographie de thorax. Cette stratégie de détection précoce des épanchements pleuraux semblait associée à une réduction du nombre d'échecs des traitements médicaux. Les résultats définitifs sont attendus.Nous avons débuté une étude prospective évaluant la pharmacocinétique de l'amoxicilline et de l'acide clavulanique dans les épanchements parapneumoniques compliqués. Nous avons proposé la réalisation d'une étude multicentrique randomisée comparant l'efficacité respective d'un traitement fibrinolytique (altéplase + DNase) et des lavages intrapleuraux au sérum salé dans la prise en charge des pleurésies infectieuses compliquées. Ce projet a été soumis à l'appel d'offre PHRC-N 2020. En conclusion, ce travail fournit quelques réponses aux nombreuses interrogations concernant l'épidémiologie, le diagnostic et le traitement des complications pleuroparenchymateuses des PAC
- 4 April 2026
- Published by Agence Bibliographique de l'Enseignement Supérieur
Complications pleuroparenchymateuses des pneumopathies aiguës communautaires : facteurs de risque, prise en charge diagnostique et thérapeutique
Les complications pleuropulmonaires (pleurésies infectieuses et abcès pulmonaires) des pneumopathies aiguës communautaires (PAC) sont associées à une morbidité importante mais leurs facteurs de risque et leur prise en charge sont toujours source de débat. Nous avons observé dans 2 études de cohorte (CAPAINS et CAPAINS-2) que l'utilisation d'anti-inflammatoires non stéroïdiens était associée à un risque accru de complications pleuropulmonaires, en particulier chez les patients jeunes et sans comorbidité. Dans une 3ème cohorte de patients BPCO hospitalisés pour une PAC, nous avons trouvé que l'utilisation de corticostéroïdes inhalés n'était pas associée à une modification du risque de complication pleuropulmonaire mais à une diminution de la mortalité, principalement chez les patients exacerbateurs fréquents ou avec un diagnostic de BPCO ancien (> 1 an). Finalement, nous avons mis en place une 4ème étude de cohorte pour évaluer l'impact du diabète et du contrôle glycémique sur l'évolution des PAC. Nous avons conduit une étude prospective évaluant la détection des pleurésies parapneumoniques par la réalisation d'une échographie thoracique quotidienne. Dans une analyse préliminaire, nous avons observé que près des 2/3 des patients présentaient une pleurésie parapneumonique et que l'échographie pleurale était plus sensible que la radiographie de thorax. Cette stratégie de détection précoce des épanchements pleuraux semblait associée à une réduction du nombre d'échecs des traitements médicaux. Les résultats définitifs sont attendus.Nous avons débuté une étude prospective évaluant la pharmacocinétique de l'amoxicilline et de l'acide clavulanique dans les épanchements parapneumoniques compliqués. Nous avons proposé la réalisation d'une étude multicentrique randomisée comparant l'efficacité respective d'un traitement fibrinolytique (altéplase + DNase) et des lavages intrapleuraux au sérum salé dans la prise en charge des pleurésies infectieuses compliquées. Ce projet a été soumis à l'appel d'offre PHRC-N 2020. En conclusion, ce travail fournit quelques réponses aux nombreuses interrogations concernant l'épidémiologie, le diagnostic et le traitement des complications pleuroparenchymateuses des PAC
- Open Access
- 27 December 2025
- Published by Oxford University Press (OUP) in Interdisciplinary CardioVascular and Thoracic Surgery
- Vol. 41 (1)
Polyglycolic Acid Aerostatic Patch for Air Leak Management: Results from a Decade of Pulmonary Resections Using Propensity-Score Weighting
Objectives: Prolonged air leaks are common after thoracic surgery and may be managed with synthetic aerostatic devices. This study assessed the impact of the Neoveil patch on air leak duration, hospital stay, and postoperative pneumonia. Methods: We conducted a retrospective monocentric study at Amiens University Hospital including adults undergoing lung resection between 2014 and 2024. Patients were divided into three groups: those receiving Neoveil, those not receiving it because of absence of indication, and those operated before its introduction in 2017. For analysis, the two latter groups were pooled as the Non-Neoveil arm. To address confounding, a propensity score was built from baseline covariates with standardized mean difference >5%, and inverse probability weighting was applied. The primary end-point was air leak duration, assessed with weighted linear regression. Secondary outcomes were hospital stay and postoperative pneumonia, analyzed with weighted linear and logistic regression. Results: Among 1216 patients, 313 (26%) received Neoveil. Compared with the control group, Neoveil use was associated with shorter air leak duration both before adjustment (−1.01 days; P = .0004) and after adjustment (−0.67 days; P = .0042). Hospital stay was also reduced (−1.88 days before adjustment; −1.09 days after adjustment; P = .0022). No significant difference was observed for postoperative pneumonia after adjustment (adjusted Odds Ratio 0.73, 95% Confidence Interval 0.48-1.11; P = .14). Conclusions: Neoveil use was associated with reduced air leak duration and shorter hospital stay following lung resection, without significant impact on pneumonia. These findings support its potential role in enhancing postoperative recovery and highlight the need for confirmation in prospective multicentre studies.
- 27 December 2025
- Published by Oxford University Press (OUP) in Interdisciplinary CardioVascular and Thoracic Surgery
- Vol. 41 (1)
Open AccessPolyglycolic Acid Aerostatic Patch for Air Leak Management: Results from a Decade of Pulmonary Resections Using Propensity-Score Weighting
Objectives: Prolonged air leaks are common after thoracic surgery and may be managed with synthetic aerostatic devices. This study assessed the impact of the Neoveil patch on air leak duration, hospital stay, and postoperative pneumonia. Methods: We conducted a retrospective monocentric study at Amiens University Hospital including adults undergoing lung resection between 2014 and 2024. Patients were divided into three groups: those receiving Neoveil, those not receiving it because of absence of indication, and those operated before its introduction in 2017. For analysis, the two latter groups were pooled as the Non-Neoveil arm. To address confounding, a propensity score was built from baseline covariates with standardized mean difference >5%, and inverse probability weighting was applied. The primary end-point was air leak duration, assessed with weighted linear regression. Secondary outcomes were hospital stay and postoperative pneumonia, analyzed with weighted linear and logistic regression. Results: Among 1216 patients, 313 (26%) received Neoveil. Compared with the control group, Neoveil use was associated with shorter air leak duration both before adjustment (−1.01 days; P = .0004) and after adjustment (−0.67 days; P = .0042). Hospital stay was also reduced (−1.88 days before adjustment; −1.09 days after adjustment; P = .0022). No significant difference was observed for postoperative pneumonia after adjustment (adjusted Odds Ratio 0.73, 95% Confidence Interval 0.48-1.11; P = .14). Conclusions: Neoveil use was associated with reduced air leak duration and shorter hospital stay following lung resection, without significant impact on pneumonia. These findings support its potential role in enhancing postoperative recovery and highlight the need for confirmation in prospective multicentre studies.
- Open Access
- 18 December 2025
- Published by European Respiratory Society (ERS) in ERJ Open Research
- Vol. 12 (2)
Female pulmonologists experienced poorer health and reduced quality of life related to their professional activities
Background: Despite increasing gender parity in medical school enrolment, disparities in career progression and physician well-being persist. This study evaluated professional experiences, health status and perceived gender-related barriers among pulmonologists in France. Methods: A nationwide, anonymous cross-sectional survey (546-item) was distributed to all French pulmonologists between July 2023 and February 2024. Data included work-related health disorders, career paths and gender perceptions. Gender differences in dissatisfaction and health issues were assessed (chi 2 and Fisher's exact tests). Multivariate logistic regression models were used to evaluate the impact of gender on career outcomes. Results: A total of 586 pulmonologists responded (21% response rate), 57% of whom were women; median age of 38 (interquartile range 32–49) years. Job satisfaction was moderate (mean± sd score of 3.5±1.0, out of 5)). Mental health issues were common. 51.5% reported anxiety, 22.0% burnout, 16.9% depression and over 60% had sleep disturbances. Women reported significantly higher rates of anxiety (58.8% versus 44.2%), burnout (27.9% versus 15.4%) and anxiolytic use (23.0% versus 14.5%) than men. Gender was a limiting factor in career choices (OR 1.99, 95% CI 1.41–2.80) and opportunities (OR 2.22, 95% CI 1.57–3.15), particularly among female physicians with children. Women were more likely than men to adjust their career plans for family reasons (18% versus 12%) or job offers (67.0% versus 33.1%). In multivariate analyses, gender remained a limiting factor in career choices (OR 2.00, 95% CI 1.39–2.90) and opportunities (OR 2.39, 95%CI 1.65–3.48), after adjustment for age, number of children and practice settings. Conclusion: This national survey highlights notable gender-based disparities in mental health and career advancement among French pulmonologists.
- 18 December 2025
- Published by European Respiratory Society (ERS) in ERJ Open Research
- Vol. 12 (2)
Open AccessFemale pulmonologists experienced poorer health and reduced quality of life related to their professional activities
Background: Despite increasing gender parity in medical school enrolment, disparities in career progression and physician well-being persist. This study evaluated professional experiences, health status and perceived gender-related barriers among pulmonologists in France. Methods: A nationwide, anonymous cross-sectional survey (546-item) was distributed to all French pulmonologists between July 2023 and February 2024. Data included work-related health disorders, career paths and gender perceptions. Gender differences in dissatisfaction and health issues were assessed (chi 2 and Fisher's exact tests). Multivariate logistic regression models were used to evaluate the impact of gender on career outcomes. Results: A total of 586 pulmonologists responded (21% response rate), 57% of whom were women; median age of 38 (interquartile range 32–49) years. Job satisfaction was moderate (mean± sd score of 3.5±1.0, out of 5)). Mental health issues were common. 51.5% reported anxiety, 22.0% burnout, 16.9% depression and over 60% had sleep disturbances. Women reported significantly higher rates of anxiety (58.8% versus 44.2%), burnout (27.9% versus 15.4%) and anxiolytic use (23.0% versus 14.5%) than men. Gender was a limiting factor in career choices (OR 1.99, 95% CI 1.41–2.80) and opportunities (OR 2.22, 95% CI 1.57–3.15), particularly among female physicians with children. Women were more likely than men to adjust their career plans for family reasons (18% versus 12%) or job offers (67.0% versus 33.1%). In multivariate analyses, gender remained a limiting factor in career choices (OR 2.00, 95% CI 1.39–2.90) and opportunities (OR 2.39, 95%CI 1.65–3.48), after adjustment for age, number of children and practice settings. Conclusion: This national survey highlights notable gender-based disparities in mental health and career advancement among French pulmonologists.
- Open Access
- 31 July 2025
- Published by Elsevier in Infectious Diseases Now
- Vol. 55 (6) , 105129
Lung ultrasonography for community-acquired pneumonia diagnosis
- 31 July 2025
- Published by Elsevier in Infectious Diseases Now
- Vol. 55 (6) , 105129
Open AccessLung ultrasonography for community-acquired pneumonia diagnosis
- 30 July 2025
- Published by Elsevier in Infectious Diseases Now
- Vol. 55 (6) , 105124
Towards more personalized management of pneumonia: recent progress and outstanding issues
- 30 July 2025
- Published by Elsevier in Infectious Diseases Now
- Vol. 55 (6) , 105124
Towards more personalized management of pneumonia: recent progress and outstanding issues
- Open Access
- 30 July 2025
- Published by Elsevier in Infectious Diseases Now
- Vol. 55 (6) , 105127
Indications for corticosteroids in the treatment of Community-Acquired pneumonia
- 30 July 2025
- Published by Elsevier in Infectious Diseases Now
- Vol. 55 (6) , 105127
Open AccessIndications for corticosteroids in the treatment of Community-Acquired pneumonia
- Open Access
- 30 July 2025
- Published by Elsevier in Infectious Diseases Now
- Vol. 55 (6) , 105126
Antibiotic combination indications for the treatment of community-acquired acute pneumonia
- 30 July 2025
- Published by Elsevier in Infectious Diseases Now
- Vol. 55 (6) , 105126
Open AccessAntibiotic combination indications for the treatment of community-acquired acute pneumonia
- Open Access
- 14 January 2025
- Published by Elsevier in Respiratory Medicine and Research
- Vol. 87, 101155
Role of narrow band imaging in assessing bronchial mucosal hypervascularization in COVID-19 patients
- 14 January 2025
- Published by Elsevier in Respiratory Medicine and Research
- Vol. 87, 101155
Open AccessRole of narrow band imaging in assessing bronchial mucosal hypervascularization in COVID-19 patients
- Open Access
- 29 November 2024
- Published by Springer Nature in Environmental Health
- Vol. 23 (1) , 1-9
Association between acute exacerbation of chronic obstructive pulmonary disease and short-term exposure to ambient air pollutants in France
Ambient air pollution is recognized as a major risk factor for chronic obstructive pulmonary disease (COPD) which is the third leading cause of death worldwide. We examined whether variations in daily outdoor air pollutants levels were associated with excess hospital emergency room visits (ERV) for acute exacerbation of COPD (AECOPD). This two-center ecological cohort study was conducted in Amiens, France. We collected all consecutive ERV for AECOPD throughout 2017 and developed single pollutant models to assess the association between AECOPD and nitrogen dioxide (NO2), ozone (O3), or particulate matter (PM2.5 and PM10) levels, while adjusting for temperature, hygrometry, influenza circulation and pollen allergy risk. For a subgroup of patients, we also applied geographical modeling to analyze annual exposure to outdoor air pollutants. We recorded 240 ERV among 168 COPD patients in 2017 and identified 9 peaks of ERV. There was a statistically significant positive correlation between the daily ERV for AECOPD and the daily average concentrations of PM2.5 (RR = 1.06 (95%CI = [1.00–1.11]), p = 0.049), but no correlation with NO2, O3 or PM10 (p = 0.073, p = 0.114 and p = 0.119, respectively). Our geographical modeling study revealed that long-term exposure to any of the four outdoor air pollutants was not associated with more frequent AECOPD. Even though the pollution levels measured generally remained below or near the 2021 short-term air quality guidelines issued by the World Health Organization, significant aggregate-level associations were found between severe AECOPD leading to ERV and daily concentrations of PM2.5. NCT03079661.
- 29 November 2024
- Published by Springer Nature in Environmental Health
- Vol. 23 (1) , 1-9
Open AccessAssociation between acute exacerbation of chronic obstructive pulmonary disease and short-term exposure to ambient air pollutants in France
Ambient air pollution is recognized as a major risk factor for chronic obstructive pulmonary disease (COPD) which is the third leading cause of death worldwide. We examined whether variations in daily outdoor air pollutants levels were associated with excess hospital emergency room visits (ERV) for acute exacerbation of COPD (AECOPD). This two-center ecological cohort study was conducted in Amiens, France. We collected all consecutive ERV for AECOPD throughout 2017 and developed single pollutant models to assess the association between AECOPD and nitrogen dioxide (NO2), ozone (O3), or particulate matter (PM2.5 and PM10) levels, while adjusting for temperature, hygrometry, influenza circulation and pollen allergy risk. For a subgroup of patients, we also applied geographical modeling to analyze annual exposure to outdoor air pollutants. We recorded 240 ERV among 168 COPD patients in 2017 and identified 9 peaks of ERV. There was a statistically significant positive correlation between the daily ERV for AECOPD and the daily average concentrations of PM2.5 (RR = 1.06 (95%CI = [1.00–1.11]), p = 0.049), but no correlation with NO2, O3 or PM10 (p = 0.073, p = 0.114 and p = 0.119, respectively). Our geographical modeling study revealed that long-term exposure to any of the four outdoor air pollutants was not associated with more frequent AECOPD. Even though the pollution levels measured generally remained below or near the 2021 short-term air quality guidelines issued by the World Health Organization, significant aggregate-level associations were found between severe AECOPD leading to ERV and daily concentrations of PM2.5. NCT03079661.